Viemed Healthcare, Inc. (VMD)
NASDAQ: VMD · Real-Time Price · USD
9.26
+0.04 (0.38%)
At close: Mar 27, 2026, 4:00 PM EDT
9.87
+0.61 (6.65%)
After-hours: Mar 27, 2026, 7:23 PM EDT

Company Description

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States.

The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment.

In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines.

Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services.

Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Viemed Healthcare, Inc.
Viemed Healthcare logo
CountryUnited States
Founded2006
IndustryMedical Devices
SectorHealthcare
Employees1,382
CEOCasey Hoyt

Contact Details

Address:
625 East Kaliste Saloom Road
Lafayette, Louisiana 70508
United States
Phone337 504 3802
Websiteviemed.com

Stock Details

Ticker SymbolVMD
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code1729149
CUSIP Number92663R105
ISIN NumberCA92663R1055
SIC Code8090

Key Executives

NamePosition
Casey HoytChief Executive Officer and Director
Michael B. Moore CRTPresident
Trae Paul FitzgeraldChief Financial Officer
William Todd ZehnderChief Operating Officer and Director
Jeremy TrahanGeneral Counsel and Corporate Secretary
Dr. William Dana Frazier M.D.Chief Medical Officer and Director
Jerome Richard Cambre IIVice President of Sales
Michael FreemanChief Business Development Officer

Latest SEC Filings

DateTypeTitle
Mar 20, 2026144Filing
Mar 19, 2026144Filing
Mar 18, 2026144Filing
Mar 16, 20268-KCurrent Report
Mar 4, 202610-KAnnual Report
Mar 4, 20268-KCurrent Report
Nov 7, 2025SCHEDULE 13G/AFiling
Nov 7, 20258-KCurrent Report
Nov 5, 202510-QQuarterly Report
Nov 5, 20258-KCurrent Report